GREENWICH, Conn. (PRWEB)
January 19, 2022

WINFertility (WIN), the leading global fertility benefits management company, adds Ava, an AI-driven digital health company that advances women’s reproductive health, to WINFertility’s newly launched WIN Family Services, a comprehensive and inclusive family-building advocacy and support program for employers. WIN’s robust suite of fertility management tools, available to its industry-leading roster of employer clients, further enhances WIN’s best-in-class fertility benefits management program, and will allow for earlier and more effective intervention in the family-building process.

The WIN Family Services program enhances WIN’s unique live, nurse-led fertility patient advocacy. WIN’s preconception through postpartum services include ovulation tracking, nutrition support, at-home male factor testing, maternity education, return-to-work coaching and parenting. This broad and customizable offering meets the employer market demand for additional family-building support services. WIN Family Services digital family-building support solutions for employer groups will be accessible through the WIN app and supported by WIN’s best-in-class Customer Service Team and clinical Nurse Care Managers.

Ava’s FDA-cleared and highly accurate fertility tracking sensor bracelet detects the five most fertile days of a woman’s cycle in real-time, while also delivering personalized insight about reproductive health and pregnancy. Offering a preconception digital tracking solution is a way for employers to save on costs related to family-building. Preconception ovulation tracking increases an employee’s odds of natural conception by providing them with data about when their chances for pregnancy are highest.

“WIN is excited to offer our clients and patients innovative support services, through the WIN Family Services program, that continue to improve outcomes, reduce stress and lower the cost of building a family for the patient and employer,” says Roger Shedlin, JD, MD and CEO of WINFertility. “The Ava collaboration with our WIN Family Services program supports our goal of helping our patients to start and build their families.”

“Our partnership with WIN is an opportunity to meet employees at the very beginning of the fertility journey,” said Ava CEO Lea von Bidder. “Ava’s AI-driven ovulation tracking is a highly accurate and cost-effective way to increase the chances of natural conception.”

About WINFertility

WINFertility is the nation’s leading family-building and fertility benefit management company, providing comprehensive solutions for employers, health plans and consumers. From fertility management, including medical treatment, pharmacy and genetics to surrogacy and adoption, WINFertility has helped more than 150,000 families by providing access to the best doctors, technology, and support. WIN works with the nation’s leading reproductive endocrinologists and integrates with national and regional insurance carriers, as well as the nation’s largest pharmacy benefit managers, to deliver the most advanced and effective fertility treatments and family-building solutions. WIN Nurse Care Managers navigate patients through the often complex process, providing clinical oversight, emotional support, advocacy, and education throughout the journey. Patients and clients that utilize WIN’s program see higher pregnancy rates, fewer multiple gestations, more efficient Rx utilization, and lower costs. The company headquarters are based in Greenwich, CT. For more information on Ava, visit https://www.winfertility.com.

About Ava

Ava is a digital health company with offices in Zurich, San Francisco, Belgrade, and Makati that advances women’s reproductive health by bringing together artificial intelligence and clinical research. It has the first FDA-cleared fertility tracking wearable. Its fertility tracking sensor bracelet detects the five most fertile days of a woman’s cycle in real-time with 90% accuracy, while also delivering personalized insight about reproductive health and pregnancy. Launched in 2016, Ava Fertility has a large, happy user base, clinical validation in multiple clinical trials, and regulatory validation through its FDA and European clearances. Studies for the clinical use of Ava have been conducted in collaboration with academic partners around the world, including at the University Hospital of Zurich, Switzerland, Columbia University, and Northwestern University’s Feinberg School of Medicine. Ava was voted Best of Baby Tech at CES, named a Women’s Health “Editors’ Choice” product and has been honored as a CB Insights Digital Health 150 company. Ava is FDA cleared, and CE-marked according to MDR 2017/745 for the purpose of measuring and displaying physiological parameters to facilitate conception and to provide general information on health and wellness to users. For more information on Ava, visit http://www.avawomen.com.

Share article on social media or email: